DCTs involve conducting clinical trials remotely, with participants receiving study-related services at their homes or other convenient locations, rather than traveling to a clinical research site. This shift to the patient's environment eliminates the need for frequent site visits, which can be inconvenient, time-consuming, and costly for participants.

Hybrid clinical trials combine elements of both centralized and decentralized trials. In a hybrid trial, some participants may receive study-related services at a clinical research site, while others may receive them remotely. This approach can offer the best of both worlds, potentially improving accessibility while maintaining the ability to closely monitor participants at a central location.

Increased accessibility

Improved patient engagement

Enhanced data quality

Technology infrastructure

Patient recruitment and retention

Regulatory compliance